New Serotonin Transporter Imaging Agents
University of Pennsylvania
posted on 08/26/2009
New Serotonin Transporter Imaging Agents
Detailed Description
Anxiety and depressive disorders have been associated with the level of serotonin in the brain. These disorders are typically treated by prescribing a selective serotonin reuptake inhibitor (SSRI). SSRI drugs (i.e., Prozacô) will bind with the serotonin
File Number: L1993
This innovation currently is not available for online licensing. Please contact Jacqueline Harris at University of Pennsylvania for more information.
Find more innovations
